Brentuximab Vedotin Injection

Generic name: Pronounced as (bren tux' i mab ve doe' tin)
Brand names
  • Adcetris®
Click on drug name to hear pronunciation

Medical Content Reviewed By HelloPharmacist Staff

Last Revised - 02/15/2019

Receiving brentuximab vedotin injection may increase the risk that you will develop progressive multifocal leukoencephalopathy (PML; a rare infection of the brain that cannot be treated, prevented, or cured and that usually causes death or severe disability). Tell your doctor if you have or have ever had a condition that affects your immune system. Tell your doctor and pharmacist if you are taking any medications that suppress the immune system. If you experience any of the following symptoms, stop receiving brentuximab vedotin injection and call your doctor immediately: decreased strength or weakness on one side of the body; difficulty walking; loss of coordination; headache; confusion; difficulty thinking clearly; memory loss; changes in mood or usual behavior; difficulty speaking; or vision changes.

Keep all appointments with your doctor and the laboratory. Your doctor may order certain tests to check your body's response to brentuximab vedotin injection.

Talk to your doctor about the risks of receiving brentuximab vedotin injection.

Brentuximab vedotin injection is used

  • in combination with other chemotherapy medications to treat Hodgkin's lymphoma (Hodgkin's disease) in those who have not previously received treatment,

  • to treat Hodgkin's lymphoma in those who are at risk for their disease to become worse or come back after a stem cell transplant (procedure that replaces diseased bone marrow with healthy bone marrow),

  • to treat Hodgkin's lymphoma in those who did not respond to a stem cell transplant (procedure that replaces diseased bone marrow with healthy bone marrow) or at least two treatment periods of chemotherapy,

  • in combination with other chemotherapy medications to treat anaplastic large cell lymphoma (sALCL; a type of non-Hodgkin lymphoma) and other certain types of peripheral T-cell lymphomas (PTCL; a type of non-Hodgkin lymphoma) in those who have not previously received treatment,

  • to treat systemic sALCL in those who did not respond to another treatment period of chemotherapy, ,

  • to treat a certain type of primary cutaneous anaplastic large cell lymphoma (pcALCL; a type of non-Hodgkin's lymphoma) in people who have previously received another treatment.

Brentuximab vedotin injection is in a class of medications called antibody-drug conjugates. It works by killing cancer cells.

Brentuximab vedotin injection comes as a powder to be mixed with fluid and injected over 30 minutes intravenously (into a vein) by a doctor or nurse in a medical office or hospital. When brentuximab vedotin is given to treat Hodgkin's lymphoma, sALCL, or PTCL, it is usually injected once every 3 weeks for as long as your doctor recommends that you receive treatment. When brentuximab vedotin is used in combination with chemotherapy to treat Hodgkin lymphoma as a first treatment, it is usually injected once every 2 weeks for as long as your doctor recommends that you receive treatment.

Brentuximab vedotin injection may cause serious allergic reactions, which usually occur during the infusion of the medication or within 24 hours of receiving a dose. You may receive certain medications before your infusion to prevent an allergic reaction if you had a reaction with previous treatment. Your doctor will watch you carefully while you are receiving brentuximab vedotin. If you experience any of the following symptoms, tell your doctor immediately: fever, chills, rash, hives, itching, or difficulty breathing.

Your doctor may need to delay your treatment, adjust your dose, or stop your treatment if you experience certain side effects. Be sure to tell your doctor how you are feeling during your treatment with brentuximab vedotin injection.

This medication may be prescribed for other uses; ask your doctor or pharmacist for more information.

Before receiving brentuximab vedotin injection,

  • tell your doctor and pharmacist if you are allergic to brentuximab vedotin, any other medications, or any of the ingredients in brentuximab vedotin injection. Ask your pharmacist for a list of the ingredients.

  • tell your doctor if you are receiving bleomycin. Your doctor will probably tell you not to use brentuximab vedotin injection if you are receiving this medication.

  • tell your doctor and pharmacist what other prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention any of the following: clarithromycin (Biaxin, in PrevPac), indinavir (Crixivan), itraconazole (Sporanox), ketoconazole, nefazodone, nelfinavir (Viracept), rifampin (Rifadin, Rimactane, in Rifamate, in Rifater), and ritonavir (Norvir, in Kaletra). Your doctor may need to change the doses of your medications or monitor you carefully for side effects.

  • tell your doctor if you have or have ever had liver or kidney disease.

  • tell your doctor if you are pregnant or plan to become pregnant. If you are a woman who is able to become pregnant, you must take a pregnancy test before starting treatment and use effective birth control during your treatment and for 6 months after your final dose. If you are male with a female partner who is pregnant or could become pregnant, you must use effective birth control during your treatment and for 6 months after your final dose. Talk to your doctor about birth control methods that you can use. If you or your partner become pregnant while receiving brentuximab vedotin injection, call your doctor immediately. Brentuximab vedotin injection may harm the fetus.

  • tell your doctor if you are breastfeeding. You should not breastfeed while you are receiving brentuximab vedotin injection.

  • you should know that this medication may decrease fertility in men. Talk to your doctor about the risks of receiving brentuximab vedotin injection.

Unless your doctor tells you otherwise, continue your normal diet.

  • Brentuximab vedotin injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away:

    • constipation

    • mouth sores

    • decreased appetite

    • weight loss

    • tiredness

    • dizziness

    • weakness

    • difficulty falling asleep or staying asleep

    • anxiety

    • dry skin

    • hair loss

    • night sweats

    • joint, bone, muscle, back, arm, or leg pain

    • muscle spasms

  • Some side effects can be serious. If you experience any of these symptoms or those listed in the IMPORTANT WARNING section, call your doctor immediately or get emergency medical treatment:

    • unusual bleeding or bruising

    • numbness, burning, or tingling in the hands, arms, feet, or legs

    • muscle weakness

    • peeling or blistering skin

    • hives

    • rash

    • itching

    • nausea

    • vomiting

    • diarrhea

    • cough or shortness of breath

    • decreased urination

    • swelling of the hands, feet, ankles, or lower legs

    • difficult, painful, or frequent urination

    • fever, chills, cough, or other signs of infection

    • ongoing pain that begins in the stomach area but may spread to the back

    • pale skin

    • yellowing of the skin or eyes

    • pain or discomfort in the right upper stomach area

    • dark urine

    • clay-colored bowel movements

    • stomach pain

    • unusual bleeding or bruising

    • black and tarry stools

    • red blood in stools

  • Brentuximab vedotin injection may cause other side effects. Call your doctor if you have any unusual problems while receiving this medication.

  • If you experience a serious side effect, you or your doctor may send a report to the Food and Drug Administration's (FDA) MedWatch Adverse Event Reporting program online (http://www.fda.gov/Safety/MedWatch) or by phone (1-800-332-1088).

In case of overdose, call the poison control helpline at 1-800-222-1222. Information is also available online at https://www.poisonhelp.org/help. If the victim has collapsed, had a seizure, has trouble breathing, or can't be awakened, immediately call emergency services at 911.

Symptoms of overdose may include the following:

  • fever, chills, cough, or other signs of infection

Ask your pharmacist any questions you have about brentuximab vedotin injection.

It is important for you to keep a written list of all of the prescription and nonprescription (over-the-counter) medicines you are taking, as well as any products such as vitamins, minerals, or other dietary supplements. You should bring this list with you each time you visit a doctor or if you are admitted to a hospital. It is also important information to carry with you in case of emergencies.

Drug Interaction
Leflunomide Leflunomide The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Leflunomide.
Delavirdine Delavirdine The metabolism of Brentuximab vedotin can be decreased when combined with Delavirdine.
Atorvastatin Atorvastatin The metabolism of Atorvastatin can be decreased when combined with Brentuximab vedotin.
Aminophylline Aminophylline The metabolism of Aminophylline can be decreased when combined with Brentuximab vedotin.
Cilostazol Cilostazol The metabolism of Cilostazol can be decreased when combined with Brentuximab vedotin.
Erythromycin and Sulfisoxazole Erythromycin and Sulfisoxazole The serum concentration of Brentuximab vedotin can be increased when it is combined with Erythromycin.
Estrogen and Progestin (Oral Contraceptives) Estrogen and Progestin (Oral Contraceptives) Conjugated estrogens may increase the thrombogenic activities of Brentuximab vedotin.
Fenofibrate Fenofibrate The metabolism of Fenofibrate can be decreased when combined with Brentuximab vedotin.
Methylergonovine Methylergonovine The metabolism of Brentuximab vedotin can be decreased when combined with Methylergometrine.
Mycophenolate Mycophenolate The risk or severity of adverse effects can be increased when Mycophenolic acid is combined with Brentuximab vedotin.
Paregoric Paregoric The serum concentration of Brentuximab vedotin can be increased when it is combined with Morphine.
Prednisone Prednisone The risk or severity of adverse effects can be increased when Prednisone is combined with Brentuximab vedotin.
Reserpine Reserpine The serum concentration of Brentuximab vedotin can be increased when it is combined with Reserpine.
Tacrolimus Tacrolimus The serum concentration of Tacrolimus can be increased when it is combined with Brentuximab vedotin.
Triamcinolone Triamcinolone The metabolism of Brentuximab vedotin can be increased when combined with Triamcinolone.
Doxycycline Injection Doxycycline Injection The metabolism of Brentuximab vedotin can be decreased when combined with Doxycycline.
Fluconazole Injection Fluconazole Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Fluconazole.
Interferon Beta-1b Injection Interferon Beta-1b Injection The risk or severity of adverse effects can be increased when Interferon beta-1b is combined with Brentuximab vedotin.
Interferon Gamma-1b Injection Interferon Gamma-1b Injection The risk or severity of adverse effects can be increased when Interferon gamma-1b is combined with Brentuximab vedotin.
Meperidine Injection Meperidine Injection The metabolism of Meperidine can be increased when combined with Brentuximab vedotin.
Methylprednisolone Injection Methylprednisolone Injection The metabolism of Brentuximab vedotin can be increased when combined with Methylprednisolone.
Metronidazole Injection Metronidazole Injection The metabolism of Brentuximab vedotin can be decreased when combined with Metronidazole.
Morphine Injection Morphine Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Morphine.
Zidovudine Injection Zidovudine Injection The risk or severity of adverse effects can be increased when Zidovudine is combined with Brentuximab vedotin.
Cyclosporine Cyclosporine Brentuximab vedotin may increase the immunosuppressive activities of Cyclosporine.
Dofetilide Dofetilide The metabolism of Dofetilide can be decreased when combined with Brentuximab vedotin.
Hydroxychloroquine Hydroxychloroquine The risk or severity of adverse effects can be increased when Hydroxychloroquine is combined with Brentuximab vedotin.
Orlistat Orlistat The metabolism of Brentuximab vedotin can be increased when combined with Orlistat.
Oxcarbazepine Oxcarbazepine The metabolism of Brentuximab vedotin can be increased when combined with Oxcarbazepine.
Temozolomide Temozolomide The risk or severity of adverse effects can be increased when Temozolomide is combined with Brentuximab vedotin.
Anakinra Anakinra The metabolism of Brentuximab vedotin can be increased when combined with Anakinra.
Linezolid Linezolid The risk or severity of adverse effects can be increased when Linezolid is combined with Brentuximab vedotin.
Etanercept Injection Etanercept Injection The metabolism of Brentuximab vedotin can be increased when combined with Etanercept.
Modafinil Modafinil The metabolism of Brentuximab vedotin can be increased when combined with Modafinil.
Tenofovir Tenofovir The metabolism of Tenofovir can be decreased when combined with Brentuximab vedotin.
Sirolimus Sirolimus The metabolism of Sirolimus can be decreased when combined with Brentuximab vedotin.
Epinephrine Injection Epinephrine Injection The metabolism of Brentuximab vedotin can be decreased when combined with Epinephrine.
Epirubicin Epirubicin The risk or severity of adverse effects can be increased when Epirubicin is combined with Brentuximab vedotin.
Zonisamide Zonisamide The serum concentration of Brentuximab vedotin can be increased when it is combined with Zonisamide.
Adalimumab Injection Adalimumab Injection The metabolism of Brentuximab vedotin can be increased when combined with Adalimumab.
Aripiprazole Aripiprazole The metabolism of Aripiprazole can be decreased when combined with Brentuximab vedotin.
Glatiramer Injection Glatiramer Injection The risk or severity of adverse effects can be increased when Glatiramer is combined with Brentuximab vedotin.
Atazanavir Atazanavir The metabolism of Atazanavir can be decreased when combined with Brentuximab vedotin.
Mefloquine Mefloquine The metabolism of Brentuximab vedotin can be decreased when combined with Mefloquine.
Omalizumab Injection Omalizumab Injection The risk or severity of adverse effects can be increased when Omalizumab is combined with Brentuximab vedotin.
Rosuvastatin Rosuvastatin The metabolism of Rosuvastatin can be decreased when combined with Brentuximab vedotin.
Vardenafil Vardenafil The metabolism of Vardenafil can be decreased when combined with Brentuximab vedotin.
Alfuzosin Alfuzosin The metabolism of Alfuzosin can be decreased when combined with Brentuximab vedotin.
Aprepitant Aprepitant The metabolism of Brentuximab vedotin can be decreased when combined with Aprepitant.
Tegaserod Tegaserod The serum concentration of Brentuximab vedotin can be increased when it is combined with Tegaserod.
Progesterone Progesterone The metabolism of Brentuximab vedotin can be increased when combined with Progesterone.
Darbepoetin Alfa Injection Darbepoetin Alfa Injection The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Brentuximab vedotin.
Infliximab Injection Infliximab Injection The metabolism of Brentuximab vedotin can be increased when combined with Infliximab.
Rifaximin Rifaximin The metabolism of Brentuximab vedotin can be increased when combined with Rifaximin.
Duloxetine Duloxetine The metabolism of Duloxetine can be decreased when combined with Brentuximab vedotin.
Norethindrone Norethindrone The metabolism of Norethisterone can be decreased when combined with Brentuximab vedotin.
Bosentan Bosentan The metabolism of Brentuximab vedotin can be increased when combined with Bosentan.
Natalizumab Injection Natalizumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Natalizumab.
Erlotinib Erlotinib The metabolism of Brentuximab vedotin can be decreased when combined with Erlotinib.
Eszopiclone Eszopiclone The metabolism of Eszopiclone can be decreased when combined with Brentuximab vedotin.
Voriconazole Voriconazole The metabolism of Brentuximab vedotin can be decreased when combined with Voriconazole.
Peginterferon Alfa-2a Injection Peginterferon Alfa-2a Injection The risk or severity of adverse effects can be increased when Peginterferon alfa-2a is combined with Brentuximab vedotin.
Peginterferon Alfa-2b (PEG-Intron) Peginterferon Alfa-2b (PEG-Intron) The risk or severity of adverse effects can be increased when Peginterferon alfa-2b is combined with Brentuximab vedotin.
Fentanyl Fentanyl The metabolism of Fentanyl can be decreased when combined with Brentuximab vedotin.
Deferasirox Deferasirox The metabolism of Brentuximab vedotin can be increased when combined with Deferasirox.
Tipranavir Tipranavir The serum concentration of Brentuximab vedotin can be increased when it is combined with Tipranavir.
Felbamate Felbamate The metabolism of Brentuximab vedotin can be increased when combined with Felbamate.
Ranolazine Ranolazine The serum concentration of Brentuximab vedotin can be increased when it is combined with Ranolazine.
Abatacept Injection Abatacept Injection The metabolism of Brentuximab vedotin can be increased when combined with Abatacept.
Imatinib Imatinib The metabolism of Brentuximab vedotin can be decreased when combined with Imatinib.
Sitagliptin Sitagliptin The serum concentration of Brentuximab vedotin can be increased when it is combined with Sitagliptin.
Bevacizumab Injection Bevacizumab Injection The risk or severity of adverse effects can be increased when Bevacizumab is combined with Brentuximab vedotin.
Gefitinib Gefitinib The metabolism of Brentuximab vedotin can be decreased when combined with Gefitinib.
Paliperidone Paliperidone The serum concentration of Brentuximab vedotin can be increased when it is combined with Paliperidone.
Bortezomib Bortezomib The metabolism of Brentuximab vedotin can be decreased when combined with Bortezomib.
Clofarabine Injection Clofarabine Injection The risk or severity of adverse effects can be increased when Clofarabine is combined with Brentuximab vedotin.
Hepatitis B Vaccine Hepatitis B Vaccine The therapeutic efficacy of Hepatitis B Vaccine (Recombinant) can be decreased when used in combination with Brentuximab vedotin.
Influenza Vaccine, Inactivated or Recombinant Influenza Vaccine, Inactivated or Recombinant The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen (formaldehyde inactivated) can be decreased when used in combination with Brentuximab vedotin.
Influenza Vaccine, Live Intranasal Influenza Vaccine, Live Intranasal The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Brentuximab vedotin.
Live Shingles (Zoster) Vaccine (ZVL) Live Shingles (Zoster) Vaccine (ZVL) The risk or severity of infection can be increased when Varicella Zoster Vaccine (Live/attenuated) is combined with Brentuximab vedotin.
Oxaliplatin Injection Oxaliplatin Injection The risk or severity of adverse effects can be increased when Oxaliplatin is combined with Brentuximab vedotin.
Posaconazole Posaconazole The metabolism of Brentuximab vedotin can be decreased when combined with Posaconazole.
Primaquine Primaquine The metabolism of Brentuximab vedotin can be decreased when combined with Primaquine.
Rituximab Injection Rituximab Injection The risk or severity of adverse effects can be increased when Rituximab is combined with Brentuximab vedotin.
Cetuximab Injection Cetuximab Injection The risk or severity of adverse effects can be increased when Cetuximab is combined with Brentuximab vedotin.
Darunavir Darunavir The serum concentration of Brentuximab vedotin can be increased when it is combined with Darunavir.
Pemetrexed Injection Pemetrexed Injection The risk or severity of adverse effects can be increased when Pemetrexed is combined with Brentuximab vedotin.
Ranibizumab Injection Ranibizumab Injection The risk or severity of adverse effects can be increased when Ranibizumab is combined with Brentuximab vedotin.
Retapamulin Retapamulin The metabolism of Retapamulin can be decreased when combined with Brentuximab vedotin.
Vorinostat Vorinostat The risk or severity of adverse effects can be increased when Vorinostat is combined with Brentuximab vedotin.
Sorafenib Sorafenib The serum concentration of Brentuximab vedotin can be increased when it is combined with Sorafenib.
Sunitinib Sunitinib The metabolism of Brentuximab vedotin can be decreased when combined with Sunitinib.
Lapatinib Lapatinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Lapatinib.
Dasatinib Dasatinib The metabolism of Dasatinib can be decreased when combined with Brentuximab vedotin.
Panitumumab Injection Panitumumab Injection The risk or severity of adverse effects can be increased when Panitumumab is combined with Brentuximab vedotin.
Armodafinil Armodafinil The metabolism of Brentuximab vedotin can be increased when combined with Armodafinil.
Azacitidine Injection Azacitidine Injection The risk or severity of adverse effects can be increased when Azacitidine is combined with Brentuximab vedotin.
Ivermectin Ivermectin The metabolism of Brentuximab vedotin can be increased when combined with Ivermectin.
Temsirolimus Temsirolimus The serum concentration of Brentuximab vedotin can be increased when it is combined with Temsirolimus.
Nelarabine Injection Nelarabine Injection The risk or severity of adverse effects can be increased when Nelarabine is combined with Brentuximab vedotin.
Lenalidomide Lenalidomide The risk or severity of adverse effects can be increased when Lenalidomide is combined with Brentuximab vedotin.
Nilotinib Nilotinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Nilotinib.
Toremifene Toremifene The serum concentration of Brentuximab vedotin can be increased when it is combined with Toremifene.
Bexarotene Bexarotene The metabolism of Brentuximab vedotin can be increased when combined with Bexarotene.
Budesonide Budesonide The metabolism of Brentuximab vedotin can be increased when combined with Budesonide.
Chloramphenicol Injection Chloramphenicol Injection The metabolism of Brentuximab vedotin can be decreased when combined with Chloramphenicol.
Decitabine Injection Decitabine Injection The risk or severity of adverse effects can be increased when Decitabine is combined with Brentuximab vedotin.
Etravirine Etravirine The serum concentration of Brentuximab vedotin can be decreased when it is combined with Etravirine.
Arsenic Trioxide Injection Arsenic Trioxide Injection The risk or severity of adverse effects can be increased when Arsenic trioxide is combined with Brentuximab vedotin.
Mitoxantrone Injection Mitoxantrone Injection The metabolism of Brentuximab vedotin can be decreased when combined with Mitoxantrone.
Desvenlafaxine Desvenlafaxine The metabolism of Brentuximab vedotin can be decreased when combined with Desvenlafaxine.
Tretinoin Tretinoin The risk or severity of adverse effects can be increased when Tretinoin is combined with Brentuximab vedotin.
Bendamustine Injection Bendamustine Injection The risk or severity of adverse effects can be increased when Bendamustine is combined with Brentuximab vedotin.
Pilocarpine Pilocarpine The metabolism of Brentuximab vedotin can be decreased when combined with Pilocarpine.
Certolizumab Injection Certolizumab Injection The metabolism of Certolizumab pegol can be increased when combined with Brentuximab vedotin.
Ixabepilone Injection Ixabepilone Injection The metabolism of Brentuximab vedotin can be decreased when combined with Ixabepilone.
Irinotecan Injection Irinotecan Injection The metabolism of Brentuximab vedotin can be decreased when combined with Irinotecan.
Estramustine Estramustine The risk or severity of adverse effects can be increased when Estramustine is combined with Brentuximab vedotin.
Mitotane Mitotane The metabolism of Brentuximab vedotin can be increased when combined with Mitotane.
Alemtuzumab Injection (Chronic Lymphocytic Leukemia) Alemtuzumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Alemtuzumab is combined with Brentuximab vedotin.
Rufinamide Rufinamide The metabolism of Rufinamide can be increased when combined with Brentuximab vedotin.
Silodosin Silodosin The serum concentration of Brentuximab vedotin can be increased when it is combined with Silodosin.
Midazolam Midazolam The serum concentration of Midazolam can be increased when it is combined with Brentuximab vedotin.
Dexrazoxane Injection Dexrazoxane Injection The risk or severity of adverse effects can be increased when Dexrazoxane is combined with Brentuximab vedotin.
Ibritumomab Injection Ibritumomab Injection The risk or severity of adverse effects can be increased when Ibritumomab tiuxetan is combined with Brentuximab vedotin.
Milnacipran Milnacipran The metabolism of Brentuximab vedotin can be decreased when combined with Milnacipran.
Iloperidone Iloperidone The metabolism of Iloperidone can be decreased when combined with Brentuximab vedotin.
Lacosamide Lacosamide The metabolism of Lacosamide can be decreased when combined with Brentuximab vedotin.
Everolimus Everolimus The metabolism of Everolimus can be decreased when combined with Brentuximab vedotin.
Tolvaptan (low blood sodium) Tolvaptan (low blood sodium) The metabolism of Brentuximab vedotin can be decreased when combined with Tolvaptan.
Dronedarone Dronedarone The serum concentration of Brentuximab vedotin can be increased when it is combined with Dronedarone.
Pralatrexate Injection Pralatrexate Injection The risk or severity of adverse effects can be increased when Pralatrexate is combined with Brentuximab vedotin.
Romidepsin Injection Romidepsin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Romidepsin.
Topotecan Topotecan The metabolism of Brentuximab vedotin can be increased when combined with Topotecan.
Ofatumumab Injection (Chronic Lymphocytic Leukemia) Ofatumumab Injection (Chronic Lymphocytic Leukemia) The risk or severity of adverse effects can be increased when Ofatumumab is combined with Brentuximab vedotin.
Golimumab Injection Golimumab Injection The metabolism of Brentuximab vedotin can be increased when combined with Golimumab.
Pazopanib Pazopanib The metabolism of Brentuximab vedotin can be decreased when combined with Pazopanib.
Albendazole Albendazole The metabolism of Albendazole can be decreased when combined with Brentuximab vedotin.
Denosumab Injection Denosumab Injection The risk or severity of adverse effects can be increased when Denosumab is combined with Brentuximab vedotin.
Tocilizumab Injection Tocilizumab Injection The metabolism of Brentuximab vedotin can be increased when combined with Tocilizumab.
Fingolimod Fingolimod Brentuximab vedotin may increase the immunosuppressive activities of Fingolimod.
Eribulin Injection Eribulin Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Eribulin.
Cabazitaxel Injection Cabazitaxel Injection The metabolism of Brentuximab vedotin can be decreased when combined with Cabazitaxel.
Ustekinumab Injection Ustekinumab Injection The risk or severity of adverse effects can be increased when Ustekinumab is combined with Brentuximab vedotin.
Acetaminophen Injection Acetaminophen Injection The metabolism of Brentuximab vedotin can be increased when combined with Acetaminophen.
Ipilimumab Injection Ipilimumab Injection The risk or severity of adverse effects can be increased when Ipilimumab is combined with Brentuximab vedotin.
Denileukin Diftitox Injection Denileukin Diftitox Injection The metabolism of Brentuximab vedotin can be decreased when combined with Aldesleukin.
Sipuleucel-T Injection Sipuleucel-T Injection The therapeutic efficacy of Sipuleucel-T can be decreased when used in combination with Brentuximab vedotin.
Belimumab Injection Belimumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Belimumab.
Busulfan Injection Busulfan Injection The metabolism of Busulfan can be decreased when combined with Brentuximab vedotin.
Roflumilast Roflumilast Roflumilast may increase the immunosuppressive activities of Brentuximab vedotin.
Linagliptin Linagliptin The serum concentration of Brentuximab vedotin can be increased when it is combined with Linagliptin.
Rilpivirine Rilpivirine The metabolism of Brentuximab vedotin can be decreased when combined with Rilpivirine.
Telaprevir Telaprevir The serum concentration of Brentuximab vedotin can be increased when it is combined with Glecaprevir.
Cyclophosphamide Injection Cyclophosphamide Injection The metabolism of Brentuximab vedotin can be increased when combined with Cyclophosphamide.
Rivaroxaban Rivaroxaban The serum concentration of Brentuximab vedotin can be increased when it is combined with Rivaroxaban.
Ticagrelor Ticagrelor The serum concentration of Brentuximab vedotin can be increased when it is combined with Ticagrelor.
Ruxolitinib Ruxolitinib The metabolism of Ruxolitinib can be decreased when combined with Brentuximab vedotin.
Vandetanib Vandetanib The serum concentration of Brentuximab vedotin can be increased when it is combined with Vandetanib.
Clobazam Clobazam The metabolism of Brentuximab vedotin can be increased when combined with Clobazam.
Vemurafenib Vemurafenib The serum concentration of Brentuximab vedotin can be increased when it is combined with Vemurafenib.
Belatacept Injection Belatacept Injection The risk or severity of adverse effects can be increased when Belatacept is combined with Brentuximab vedotin.
Ivacaftor Ivacaftor The serum concentration of Brentuximab vedotin can be increased when it is combined with Ivacaftor.
Basiliximab Injection Basiliximab Injection The risk or severity of adverse effects can be increased when Basiliximab is combined with Brentuximab vedotin.
Axitinib Axitinib The metabolism of Axitinib can be decreased when combined with Brentuximab vedotin.
Crizotinib Crizotinib The metabolism of Brentuximab vedotin can be decreased when combined with Crizotinib.
Melphalan Injection Melphalan Injection The risk or severity of adverse effects can be increased when Melphalan is combined with Brentuximab vedotin.
Cabergoline Cabergoline The metabolism of Brentuximab vedotin can be decreased when combined with Cabergoline.
Naloxone Injection Naloxone Injection The metabolism of Brentuximab vedotin can be decreased when combined with Naloxone.
Ambrisentan Ambrisentan The serum concentration of Brentuximab vedotin can be increased when it is combined with Ambrisentan.
Eculizumab Injection Eculizumab Injection The risk or severity of adverse effects can be increased when Eculizumab is combined with Brentuximab vedotin.
Pertuzumab Injection Pertuzumab Injection The risk or severity of adverse effects can be increased when Pertuzumab is combined with Brentuximab vedotin.
Carfilzomib Injection Carfilzomib Injection The serum concentration of Carfilzomib can be increased when it is combined with Brentuximab vedotin.
Enzalutamide Enzalutamide The serum concentration of Brentuximab vedotin can be increased when it is combined with Enzalutamide.
Mirabegron Mirabegron The serum concentration of Brentuximab vedotin can be increased when it is combined with Mirabegron.
Regorafenib Regorafenib The serum concentration of Brentuximab vedotin can be increased when it is combined with Regorafenib.
Bosutinib Bosutinib The metabolism of Brentuximab vedotin can be decreased when combined with Bosutinib.
Corticotropin, Repository Injection Corticotropin, Repository Injection The metabolism of Brentuximab vedotin can be increased when combined with Corticotropin.
Teriflunomide Teriflunomide The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Teriflunomide.
Tofacitinib Tofacitinib The metabolism of Tofacitinib can be decreased when combined with Brentuximab vedotin.
Dimethyl Fumarate Dimethyl Fumarate The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dimethyl fumarate.
Ponatinib Ponatinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Ponatinib.
Pomalidomide Pomalidomide The metabolism of Pomalidomide can be decreased when combined with Brentuximab vedotin.
Ado-trastuzumab Emtansine Injection Ado-trastuzumab Emtansine Injection The metabolism of Brentuximab vedotin can be decreased when combined with Trastuzumab emtansine.
Apixaban Apixaban The serum concentration of Brentuximab vedotin can be increased when it is combined with Apixaban.
Canagliflozin Canagliflozin The serum concentration of Brentuximab vedotin can be increased when it is combined with Canagliflozin.
Dabrafenib Dabrafenib The metabolism of Brentuximab vedotin can be increased when combined with Dabrafenib.
Trametinib Trametinib The metabolism of Brentuximab vedotin can be increased when combined with Trametinib.
Dolutegravir Dolutegravir The serum concentration of Brentuximab vedotin can be increased when it is combined with Dolutegravir.
Afatinib Afatinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Afatinib.
Perampanel Perampanel The metabolism of Brentuximab vedotin can be increased when combined with Perampanel.
Ibrutinib Ibrutinib The metabolism of Ibrutinib can be decreased when combined with Brentuximab vedotin.
Lomitapide Lomitapide The serum concentration of Brentuximab vedotin can be increased when it is combined with Lomitapide.
Obinutuzumab Injection Obinutuzumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Obinutuzumab.
Simeprevir Simeprevir The serum concentration of Brentuximab vedotin can be increased when it is combined with Simeprevir.
Sofosbuvir Sofosbuvir The serum concentration of Brentuximab vedotin can be increased when it is combined with Sofosbuvir.
Apremilast Apremilast The metabolism of Brentuximab vedotin can be increased when combined with Apremilast.
Ramucirumab Injection Ramucirumab Injection The risk or severity of adverse effects can be increased when Ramucirumab is combined with Brentuximab vedotin.
Ceritinib Ceritinib The metabolism of Ceritinib can be decreased when combined with Brentuximab vedotin.
Siltuximab Injection Siltuximab Injection The metabolism of Siltuximab can be increased when combined with Brentuximab vedotin.
Eslicarbazepine Eslicarbazepine The metabolism of Brentuximab vedotin can be increased when combined with Eslicarbazepine.
Vedolizumab Injection Vedolizumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Vedolizumab.
Belinostat Injection Belinostat Injection The risk or severity of adverse effects can be increased when Belinostat is combined with Brentuximab vedotin.
Idelalisib Idelalisib The metabolism of Idelalisib can be decreased when combined with Brentuximab vedotin.
Testosterone Injection Testosterone Injection The metabolism of Brentuximab vedotin can be increased when combined with Testosterone.
Oritavancin Injection Oritavancin Injection The metabolism of Brentuximab vedotin can be increased when combined with Oritavancin.
Vorapaxar Vorapaxar The serum concentration of Brentuximab vedotin can be increased when it is combined with Vorapaxar.
Suvorexant Suvorexant The serum concentration of Brentuximab vedotin can be increased when it is combined with Suvorexant.
Dulaglutide Injection Dulaglutide Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dulaglutide.
Pembrolizumab Injection Pembrolizumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Pembrolizumab.
Edoxaban Edoxaban The serum concentration of Brentuximab vedotin can be increased when it is combined with Edoxaban.
Nivolumab Injection Nivolumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Nivolumab.
Peginterferon Beta-1a Injection Peginterferon Beta-1a Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Peginterferon beta-1a.
Olaparib Olaparib The metabolism of Olaparib can be decreased when combined with Brentuximab vedotin.
Blinatumomab Injection Blinatumomab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Blinatumomab.
Tasimelteon Tasimelteon The metabolism of Tasimelteon can be decreased when combined with Brentuximab vedotin.
Lanreotide Injection Lanreotide Injection The metabolism of Brentuximab vedotin can be decreased when combined with Lanreotide.
Pirfenidone Pirfenidone The risk or severity of adverse effects can be increased when Pirfenidone is combined with Brentuximab vedotin.
Nintedanib Nintedanib The metabolism of Nintedanib can be decreased when combined with Brentuximab vedotin.
Secukinumab Injection Secukinumab Injection The metabolism of Secukinumab can be increased when combined with Brentuximab vedotin.
Palbociclib Palbociclib The serum concentration of Brentuximab vedotin can be increased when it is combined with Palbociclib.
Lenvatinib Lenvatinib The metabolism of Brentuximab vedotin can be increased when combined with Lenvatinib.
Panobinostat Panobinostat The metabolism of Brentuximab vedotin can be decreased when combined with Panobinostat.
Dinutuximab Injection Dinutuximab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dinutuximab.
Haloperidol Injection Haloperidol Injection The serum concentration of Haloperidol can be increased when it is combined with Brentuximab vedotin.
Isavuconazonium Injection Isavuconazonium Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Isavuconazonium.
Sonidegib Sonidegib The metabolism of Sonidegib can be decreased when combined with Brentuximab vedotin.
Alirocumab Injection Alirocumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Alirocumab.
Flibanserin Flibanserin The serum concentration of Brentuximab vedotin can be increased when it is combined with Flibanserin.
Rolapitant Rolapitant The serum concentration of Brentuximab vedotin can be increased when it is combined with Rolapitant.
Prednisolone Prednisolone The metabolism of Brentuximab vedotin can be increased when combined with Prednisolone.
Evolocumab Injection Evolocumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Evolocumab.
Daclatasvir Daclatasvir The serum concentration of Brentuximab vedotin can be increased when it is combined with Daclatasvir.
Ziprasidone Injection Ziprasidone Injection The metabolism of Ziprasidone can be decreased when combined with Brentuximab vedotin.
Cobimetinib Cobimetinib The metabolism of Cobimetinib can be decreased when combined with Brentuximab vedotin.
Mepolizumab Injection Mepolizumab Injection The risk or severity of adverse effects can be increased when Mepolizumab is combined with Brentuximab vedotin.
Trabectedin Injection Trabectedin Injection The metabolism of Brentuximab vedotin can be decreased when combined with Trabectedin.
Elotuzumab Injection Elotuzumab Injection The risk or severity of adverse effects can be increased when Elotuzumab is combined with Brentuximab vedotin.
Daratumumab Injection Daratumumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Daratumumab.
Osimertinib Osimertinib The metabolism of Osimertinib can be increased when combined with Brentuximab vedotin.
Alectinib Alectinib The metabolism of Alectinib can be decreased when combined with Brentuximab vedotin.
Ixazomib Ixazomib The metabolism of Ixazomib can be decreased when combined with Brentuximab vedotin.
Necitumumab Injection Necitumumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Necitumumab.
Rifapentine Rifapentine The metabolism of Brentuximab vedotin can be increased when combined with Rifapentine.
Lesinurad Lesinurad The metabolism of Brentuximab vedotin can be increased when combined with Lesinurad.
Amphotericin B Liposomal Injection Amphotericin B Liposomal Injection The metabolism of Brentuximab vedotin can be decreased when combined with Amphotericin B.
Dexamethasone Injection Dexamethasone Injection The metabolism of Brentuximab vedotin can be increased when combined with Dexamethasone.
Reslizumab Injection Reslizumab Injection The risk or severity of adverse effects can be increased when Reslizumab is combined with Brentuximab vedotin.
Ixekizumab Injection Ixekizumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ixekizumab.
Venetoclax Venetoclax The serum concentration of Brentuximab vedotin can be increased when it is combined with Venetoclax.
Cobicistat Cobicistat The serum concentration of Brentuximab vedotin can be increased when it is combined with Cobicistat.
Selexipag Selexipag The serum concentration of Brentuximab vedotin can be increased when it is combined with Selexipag.
Atezolizumab Injection Atezolizumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Atezolizumab.
Olaratumab Injection Olaratumab Injection The risk or severity of adverse effects can be increased when Olaratumab is combined with Brentuximab vedotin.
Rucaparib Rucaparib The serum concentration of Brentuximab vedotin can be increased when it is combined with Rucaparib.
Bezlotoxumab Injection Bezlotoxumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Bezlotoxumab.
Avelumab Injection Avelumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Avelumab.
Ribociclib Ribociclib The metabolism of Ribociclib can be decreased when combined with Brentuximab vedotin.
Brodalumab Injection Brodalumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Brodalumab.
Brigatinib Brigatinib The metabolism of Brentuximab vedotin can be increased when combined with Brigatinib.
Dupilumab Injection Dupilumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Dupilumab.
Deflazacort Deflazacort The metabolism of Deflazacort can be increased when combined with Brentuximab vedotin.
Ocrelizumab Injection Ocrelizumab Injection Ocrelizumab may increase the immunosuppressive activities of Brentuximab vedotin.
Durvalumab Injection Durvalumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Durvalumab.
Sarilumab Injection Sarilumab Injection The metabolism of Sarilumab can be increased when combined with Brentuximab vedotin.
Midostaurin Midostaurin The metabolism of Brentuximab vedotin can be increased when combined with Midostaurin.
Neratinib Neratinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Neratinib.
Guselkumab Injection Guselkumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Guselkumab.
Enasidenib Enasidenib The serum concentration of Brentuximab vedotin can be increased when it is combined with Enasidenib.
Inotuzumab Ozogamicin Injection Inotuzumab Ozogamicin Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Inotuzumab ozogamicin.
Aprepitant/Fosaprepitant Injection Aprepitant/Fosaprepitant Injection The metabolism of Fosaprepitant can be increased when combined with Brentuximab vedotin.
Copanlisib Injection Copanlisib Injection The metabolism of Copanlisib can be decreased when combined with Brentuximab vedotin.
Abemaciclib Abemaciclib The metabolism of Abemaciclib can be decreased when combined with Brentuximab vedotin.
Betrixaban Betrixaban The serum concentration of Brentuximab vedotin can be increased when it is combined with Betrixaban.
Benralizumab Injection Benralizumab Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Benralizumab.
Acalabrutinib Acalabrutinib The metabolism of Acalabrutinib can be decreased when combined with Brentuximab vedotin.
Gemtuzumab Ozogamicin Injection Gemtuzumab Ozogamicin Injection The risk or severity of adverse effects can be increased when Gemtuzumab ozogamicin is combined with Brentuximab vedotin.
Letermovir Letermovir The metabolism of Brentuximab vedotin can be decreased when combined with Letermovir.
Ertugliflozin Ertugliflozin The serum concentration of Brentuximab vedotin can be increased when it is combined with Ertugliflozin.
Buprenorphine Injection Buprenorphine Injection The metabolism of Brentuximab vedotin can be decreased when combined with Buprenorphine.
Apalutamide Apalutamide The serum concentration of Brentuximab vedotin can be decreased when it is combined with Apalutamide.
Ibalizumab-uiyk Injection Ibalizumab-uiyk Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ibalizumab.
Penicillamine Penicillamine The risk or severity of adverse effects can be increased when Penicillamine is combined with Brentuximab vedotin.
Fostamatinib Fostamatinib The metabolism of Brentuximab vedotin can be decreased when combined with Fostamatinib.
Tildrakizumab-asmn injection Tildrakizumab-asmn injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tildrakizumab.
Erenumab-aooe Injection Erenumab-aooe Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Erenumab.
Avatrombopag Avatrombopag The serum concentration of Brentuximab vedotin can be increased when it is combined with Avatrombopag.
Baricitinib Baricitinib The metabolism of Baricitinib can be decreased when combined with Brentuximab vedotin.
Burosumab-twza Injection Burosumab-twza Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Burosumab.
Eliglustat Eliglustat The metabolism of Eliglustat can be decreased when combined with Brentuximab vedotin.
Ivosidenib Ivosidenib The serum concentration of Brentuximab vedotin can be increased when it is combined with Ivosidenib.
Lusutrombopag Lusutrombopag The serum concentration of Brentuximab vedotin can be increased when it is combined with Lusutrombopag.
Elagolix Elagolix The serum concentration of Brentuximab vedotin can be increased when it is combined with Elagolix.
Cemiplimab-rwlc Injection Cemiplimab-rwlc Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Cemiplimab.
Dacomitinib Dacomitinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Dacomitinib.
Duvelisib Duvelisib The metabolism of Duvelisib can be decreased when combined with Brentuximab vedotin.
Galcanezumab-gnlm Injection Galcanezumab-gnlm Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Galcanezumab.
Mogamulizumab-kpkc Injection Mogamulizumab-kpkc Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Mogamulizumab.
Omadacycline Omadacycline The serum concentration of Brentuximab vedotin can be increased when it is combined with Omadacycline.
Sarecycline Sarecycline The serum concentration of Brentuximab vedotin can be increased when it is combined with Sarecycline.
Stiripentol Stiripentol The metabolism of Brentuximab vedotin can be decreased when combined with Stiripentol.
Talazoparib Talazoparib The serum concentration of Brentuximab vedotin can be increased when it is combined with Talazoparib.
Gilteritinib Gilteritinib The metabolism of Gilteritinib can be decreased when combined with Brentuximab vedotin.
Glasdegib Glasdegib The serum concentration of Brentuximab vedotin can be increased when it is combined with Glasdegib.
Larotrectinib Larotrectinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Larotrectinib.
Methoxy Polyethylene Glycol-Epoetin Beta Injection Methoxy Polyethylene Glycol-Epoetin Beta Injection The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol-epoetin beta is combined with Brentuximab vedotin.
Paclitaxel (with albumin) Injection Paclitaxel (with albumin) Injection The metabolism of Paclitaxel can be decreased when combined with Brentuximab vedotin.
Rifamycin Rifamycin The serum concentration of Brentuximab vedotin can be increased when it is combined with Rifamycin.
Prucalopride Prucalopride The metabolism of Prucalopride can be decreased when combined with Brentuximab vedotin.
Ravulizumab-cwvz Injection Ravulizumab-cwvz Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ravulizumab.
Emapalumab-lzsg Injection Emapalumab-lzsg Injection The metabolism of Emapalumab can be increased when combined with Brentuximab vedotin.
Romosozumab-aqqg Injection Romosozumab-aqqg Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Romosozumab.
Siponimod Siponimod The metabolism of Siponimod can be decreased when combined with Brentuximab vedotin.
Caplacizumab-yhdp Injection Caplacizumab-yhdp Injection The risk or severity of adverse effects can be increased when Caplacizumab is combined with Brentuximab vedotin.
Erdafitinib Erdafitinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Erdafitinib.
Risankizumab-rzaa Injection Risankizumab-rzaa Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Risankizumab.
Alpelisib Alpelisib The metabolism of Alpelisib can be decreased when combined with Brentuximab vedotin.
Cladribine Cladribine The risk or severity of adverse effects can be increased when Cladribine is combined with Brentuximab vedotin.
Polatuzumab vedotin-piiq Injection Polatuzumab vedotin-piiq Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Polatuzumab vedotin.
Darolutamide Darolutamide The serum concentration of Brentuximab vedotin can be increased when it is combined with Darolutamide.
Triclabendazole Triclabendazole The metabolism of Brentuximab vedotin can be decreased when combined with Triclabendazole.
Entrectinib Entrectinib The serum concentration of Entrectinib can be increased when it is combined with Brentuximab vedotin.
Pexidartinib Pexidartinib The metabolism of Pexidartinib can be decreased when combined with Brentuximab vedotin.
Istradefylline Istradefylline The serum concentration of Brentuximab vedotin can be increased when it is combined with Istradefylline.
Pitolisant Pitolisant The serum concentration of Brentuximab vedotin can be decreased when it is combined with Pitolisant.
Fedratinib Fedratinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Fedratinib.
Lefamulin Lefamulin The serum concentration of Lefamulin can be increased when it is combined with Brentuximab vedotin.
Phenytoin Injection Phenytoin Injection The metabolism of Brentuximab vedotin can be increased when combined with Phenytoin.
Fosphenytoin Injection Fosphenytoin Injection The metabolism of Fosphenytoin can be decreased when combined with Brentuximab vedotin.
Brolucizumab-dbll Injection Brolucizumab-dbll Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Brolucizumab.
Enfortumab vedotin-ejfv Injection Enfortumab vedotin-ejfv Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Enfortumab vedotin.
Fam-trastuzumab deruxtecan-nxki Injection Fam-trastuzumab deruxtecan-nxki Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Trastuzumab deruxtecan.
Zanubrutinib Zanubrutinib The metabolism of Zanubrutinib can be decreased when combined with Brentuximab vedotin.
Voxelotor Voxelotor The serum concentration of Voxelotor can be increased when it is combined with Brentuximab vedotin.
Lasmiditan Lasmiditan The serum concentration of Brentuximab vedotin can be increased when it is combined with Lasmiditan.
Ubrogepant Ubrogepant The serum concentration of Brentuximab vedotin can be increased when it is combined with Ubrogepant.
Tazemetostat Tazemetostat The metabolism of Tazemetostat can be decreased when combined with Brentuximab vedotin.
Cenobamate Cenobamate The serum concentration of Brentuximab vedotin can be decreased when it is combined with Cenobamate.
Isatuximab-irfc Injection Isatuximab-irfc Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Isatuximab.
Teprotumumab-trbw Injection Teprotumumab-trbw Injection The risk or severity of adverse effects can be increased when Teprotumumab is combined with Brentuximab vedotin.
Ozanimod Ozanimod The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Ozanimod.
Selumetinib Selumetinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Selumetinib.
Rimegepant Rimegepant The serum concentration of Brentuximab vedotin can be increased when it is combined with Rimegepant.
Tucatinib Tucatinib The metabolism of Tucatinib can be decreased when combined with Brentuximab vedotin.
Remdesivir Injection Remdesivir Injection The serum concentration of Brentuximab vedotin can be increased when it is combined with Remdesivir.
Sacituzumab govitecan-hziy Injection Sacituzumab govitecan-hziy Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Sacituzumab govitecan.
Ripretinib Ripretinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Ripretinib.
Capmatinib Capmatinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Capmatinib.
Lemborexant Lemborexant The serum concentration of Brentuximab vedotin can be increased when it is combined with Lemborexant.
Luspatercept-aamt Injection Luspatercept-aamt Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Luspatercept.
Fostemsavir Fostemsavir The serum concentration of Brentuximab vedotin can be increased when it is combined with Fostemsavir.
Octreotide Octreotide The serum concentration of Brentuximab vedotin can be increased when it is combined with Octreotide.
Belantamab Mafodotin-blmf Injection Belantamab Mafodotin-blmf Injection The serum concentration of Belantamab mafodotin can be increased when it is combined with Brentuximab vedotin.
Tafasitamab-cxix Injection Tafasitamab-cxix Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Tafasitamab.
Pralsetinib Pralsetinib The serum concentration of Brentuximab vedotin can be increased when it is combined with Pralsetinib.
Satralizumab-mwge Injection Satralizumab-mwge Injection The serum concentration of Brentuximab vedotin can be decreased when it is combined with Satralizumab.
Margetuximab-cmkb Injection Margetuximab-cmkb Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Margetuximab.
Progestin-Only (drospirenone) Oral Contraceptives Progestin-Only (drospirenone) Oral Contraceptives The metabolism of Drospirenone can be decreased when combined with Brentuximab vedotin.
Evinacumab-dgnb Injection Evinacumab-dgnb Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Evinacumab.
Vitamin E (Alpha-Tocopherol) Vitamin E (Alpha-Tocopherol) The metabolism of Brentuximab vedotin can be increased when combined with Vitamin E.
Aducanumab-avwa Injection Aducanumab-avwa Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Aducanumab.
Anifrolumab-fnia Injection Anifrolumab-fnia Injection The risk or severity of adverse effects can be increased when Brentuximab vedotin is combined with Anifrolumab.
Theophylline Theophylline The metabolism of Theophylline can be decreased when combined with Brentuximab vedotin.
Indomethacin Indomethacin The risk or severity of adverse effects can be increased when Indomethacin is combined with Brentuximab vedotin.
Trazodone Trazodone The serum concentration of Brentuximab vedotin can be decreased when it is combined with Trazodone.
Hydroxyurea Hydroxyurea The risk or severity of adverse effects can be increased when Hydroxyurea is combined with Brentuximab vedotin.
Floxuridine Floxuridine The risk or severity of adverse effects can be increased when Floxuridine is combined with Brentuximab vedotin.
Phenobarbital Phenobarbital The metabolism of Brentuximab vedotin can be increased when combined with Phenobarbital.
Methotrexate Injection Methotrexate Injection The metabolism of Brentuximab vedotin can be decreased when combined with Methotrexate.
Primidone Primidone The metabolism of Brentuximab vedotin can be increased when combined with Primidone.
Chlorpromazine Chlorpromazine The metabolism of Chlorpromazine can be increased when combined with Brentuximab vedotin.
Diazepam Diazepam The metabolism of Brentuximab vedotin can be decreased when combined with Diazepam.
Lorazepam Lorazepam The metabolism of Lorazepam can be decreased when combined with Brentuximab vedotin.
Carmustine Carmustine The risk or severity of adverse effects can be increased when Carmustine is combined with Brentuximab vedotin.
Bromocriptine Bromocriptine The metabolism of Brentuximab vedotin can be decreased when combined with Bromocriptine.
Tranylcypromine Tranylcypromine The metabolism of Brentuximab vedotin can be decreased when combined with Tranylcypromine.
Phenelzine Phenelzine The metabolism of Brentuximab vedotin can be decreased when combined with Phenelzine.
Procarbazine Procarbazine The risk or severity of adverse effects can be increased when Procarbazine is combined with Brentuximab vedotin.
Tetracycline Tetracycline The metabolism of Brentuximab vedotin can be decreased when combined with Tetracycline.
Thioguanine Thioguanine The risk or severity of adverse effects can be increased when Tioguanine is combined with Brentuximab vedotin.
Prochlorperazine Prochlorperazine The metabolism of Prochlorperazine can be decreased when combined with Brentuximab vedotin.
Bleomycin Bleomycin The risk or severity of pulmonary toxicity can be increased when Brentuximab vedotin is combined with Bleomycin.
Methadone Methadone The metabolism of Brentuximab vedotin can be increased when combined with Methadone.
Oxybutynin Oxybutynin The metabolism of Brentuximab vedotin can be decreased when combined with Oxybutynin.
Orphenadrine Orphenadrine The metabolism of Brentuximab vedotin can be decreased when combined with Orphenadrine.
Azathioprine Azathioprine The risk or severity of adverse effects can be increased when Azathioprine is combined with Brentuximab vedotin.
Phentermine Phentermine The metabolism of Phentermine can be decreased when combined with Brentuximab vedotin.
Sulfasalazine Sulfasalazine The risk or severity of adverse effects can be increased when Sulfasalazine is combined with Brentuximab vedotin.
Hydrocortisone Hydrocortisone The metabolism of Brentuximab vedotin can be increased when combined with Hydrocortisone.
Lomustine Lomustine The risk or severity of adverse effects can be increased when Lomustine is combined with Brentuximab vedotin.
Doxorubicin Doxorubicin The metabolism of Brentuximab vedotin can be decreased when combined with Doxorubicin.
Cytarabine Cytarabine The risk or severity of adverse effects can be increased when Cytarabine is combined with Brentuximab vedotin.
Mechlorethamine Mechlorethamine The risk or severity of adverse effects can be increased when Mechlorethamine is combined with Brentuximab vedotin.
Dactinomycin Dactinomycin The risk or severity of adverse effects can be increased when Dactinomycin is combined with Brentuximab vedotin.
Carbamazepine Carbamazepine The metabolism of Carbamazepine can be decreased when combined with Brentuximab vedotin.
Clonidine Clonidine The metabolism of Clonidine can be decreased when combined with Brentuximab vedotin.
Hydralazine Hydralazine The metabolism of Brentuximab vedotin can be decreased when combined with Hydralazine.
Cimetidine Cimetidine The metabolism of Brentuximab vedotin can be decreased when combined with Cimetidine.
Warfarin Warfarin The serum concentration of Warfarin can be increased when it is combined with Brentuximab vedotin.
Loperamide Loperamide The metabolism of Brentuximab vedotin can be decreased when combined with Loperamide.
Daunorubicin Daunorubicin The metabolism of Brentuximab vedotin can be decreased when combined with Daunorubicin.
Griseofulvin Griseofulvin The metabolism of Brentuximab vedotin can be increased when combined with Griseofulvin.
Digoxin Digoxin The serum concentration of Brentuximab vedotin can be increased when it is combined with Digoxin.
Loxapine Loxapine The serum concentration of Brentuximab vedotin can be increased when it is combined with Loxapine.
Quinine Quinine The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinine.
Calcitriol Calcitriol The metabolism of Brentuximab vedotin can be increased when combined with Calcitriol.
Sulfinpyrazone Sulfinpyrazone The metabolism of Brentuximab vedotin can be increased when combined with Sulfinpyrazone.
Secobarbital Secobarbital The metabolism of Brentuximab vedotin can be increased when combined with Secobarbital.
Desipramine Desipramine The metabolism of Desipramine can be decreased when combined with Brentuximab vedotin.
Probenecid Probenecid The metabolism of Brentuximab vedotin can be increased when combined with Probenecid.
Quinidine Quinidine The serum concentration of Brentuximab vedotin can be increased when it is combined with Quinidine.
Isoniazid Isoniazid The metabolism of Brentuximab vedotin can be decreased when combined with Isoniazid.
Rifampin Rifampin The serum concentration of Brentuximab vedotin can be decreased when it is combined with Rifampicin.
Valproic Acid Valproic Acid The metabolism of Brentuximab vedotin can be decreased when combined with Valproic acid.
Tamoxifen Tamoxifen The serum concentration of Brentuximab vedotin can be increased when it is combined with Tamoxifen.
Mitomycin Mitomycin The risk or severity of adverse effects can be increased when Mitomycin is combined with Brentuximab vedotin.
Levothyroxine Levothyroxine The serum concentration of Brentuximab vedotin can be decreased when it is combined with Levothyroxine.
Methimazole Methimazole The metabolism of Brentuximab vedotin can be decreased when combined with Methimazole.
Propylthiouracil Propylthiouracil The risk or severity of adverse effects can be increased when Propylthiouracil is combined with Brentuximab vedotin.
Niacin Niacin The metabolism of Brentuximab vedotin can be decreased when combined with Niacin.
Danazol Danazol The metabolism of Brentuximab vedotin can be decreased when combined with Danazol.
Nortriptyline Nortriptyline The metabolism of Nortriptyline can be decreased when combined with Brentuximab vedotin.
Amphotericin B Injection Amphotericin B Injection The metabolism of Brentuximab vedotin can be decreased when combined with Amphotericin B.
Mercaptopurine Mercaptopurine The risk or severity of adverse effects can be increased when Mercaptopurine is combined with Brentuximab vedotin.
Clomiphene Clomiphene The serum concentration of Brentuximab vedotin can be increased when it is combined with Clomifene.
Fluorouracil Injection Fluorouracil Injection The risk or severity of adverse effects can be increased when Fluorouracil is combined with Brentuximab vedotin.
Colchicine Colchicine The metabolism of Colchicine can be decreased when combined with Brentuximab vedotin.
Cephalexin Cephalexin The metabolism of Cephalexin can be decreased when combined with Brentuximab vedotin.
Dacarbazine Dacarbazine The risk or severity of adverse effects can be increased when Dacarbazine is combined with Brentuximab vedotin.
Acetazolamide Acetazolamide The metabolism of Brentuximab vedotin can be decreased when combined with Acetazolamide.
Bacillus Calmette-Guerin (BCG) Vaccine Bacillus Calmette-Guerin (BCG) Vaccine The risk or severity of infection can be increased when Bacillus calmette-guerin substrain tice live antigen is combined with Brentuximab vedotin.
Ketoconazole Ketoconazole The serum concentration of Brentuximab vedotin can be increased when it is combined with Ketoconazole.
Thiotepa Injection Thiotepa Injection The metabolism of Brentuximab vedotin can be decreased when combined with Thiotepa.
Vincristine Injection Vincristine Injection The metabolism of Brentuximab vedotin can be decreased when combined with Vincristine.
Vinblastine Vinblastine The metabolism of Brentuximab vedotin can be decreased when combined with Vinblastine.
Metoprolol Metoprolol The metabolism of Metoprolol can be decreased when combined with Brentuximab vedotin.
Chlorambucil Chlorambucil The risk or severity of adverse effects can be increased when Chlorambucil is combined with Brentuximab vedotin.
Alprazolam Alprazolam The metabolism of Alprazolam can be decreased when combined with Brentuximab vedotin.
Diltiazem Diltiazem The metabolism of Brentuximab vedotin can be decreased when combined with Diltiazem.
Nifedipine Nifedipine The metabolism of Brentuximab vedotin can be increased when combined with Nifedipine.
Verapamil Verapamil The serum concentration of Brentuximab vedotin can be increased when it is combined with Verapamil.
Cisplatin Injection Cisplatin Injection The risk or severity of adverse effects can be increased when Cisplatin is combined with Brentuximab vedotin.
Streptozocin Streptozocin The risk or severity of adverse effects can be increased when Streptozocin is combined with Brentuximab vedotin.
Etoposide Etoposide The metabolism of Brentuximab vedotin can be increased when combined with Etoposide.
Glyburide Glyburide The metabolism of Brentuximab vedotin can be decreased when combined with Glyburide.
Dicloxacillin Dicloxacillin The metabolism of Brentuximab vedotin can be increased when combined with Dicloxacillin.
Nafcillin Injection Nafcillin Injection The metabolism of Brentuximab vedotin can be increased when combined with Nafcillin.
Pimozide Pimozide The metabolism of Pimozide can be decreased when combined with Brentuximab vedotin.
Amiodarone Amiodarone The serum concentration of Brentuximab vedotin can be increased when it is combined with Amiodarone.
Lovastatin Lovastatin The metabolism of Lovastatin can be decreased when combined with Brentuximab vedotin.
Ciprofloxacin Ciprofloxacin The metabolism of Brentuximab vedotin can be decreased when combined with Ciprofloxacin.
Interferon Alfa-2b Injection Interferon Alfa-2b Injection The risk or severity of adverse effects can be increased when Interferon alfa-2b is combined with Brentuximab vedotin.
Clozapine Clozapine The metabolism of Brentuximab vedotin can be increased when combined with Clozapine.
Idarubicin Idarubicin The risk or severity of adverse effects can be increased when Idarubicin is combined with Brentuximab vedotin.
Fludarabine Injection Fludarabine Injection The risk or severity of adverse effects can be increased when Fludarabine is combined with Brentuximab vedotin.
Pentostatin Injection Pentostatin Injection The risk or severity of adverse effects can be increased when Pentostatin is combined with Brentuximab vedotin.
Clarithromycin Clarithromycin The serum concentration of Brentuximab vedotin can be increased when it is combined with Clarithromycin.
Felodipine Felodipine The metabolism of Brentuximab vedotin can be decreased when combined with Felodipine.
Pravastatin Pravastatin The serum concentration of Brentuximab vedotin can be increased when it is combined with Pravastatin.
Simvastatin Simvastatin The serum concentration of Brentuximab vedotin can be increased when it is combined with Simvastatin.
Epoetin Alfa, Injection Epoetin Alfa, Injection The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Brentuximab vedotin.
Teniposide Injection Teniposide Injection The metabolism of Brentuximab vedotin can be decreased when combined with Teniposide.
Itraconazole Itraconazole The serum concentration of Brentuximab vedotin can be increased when it is combined with Itraconazole.
Rifabutin Rifabutin The metabolism of Brentuximab vedotin can be increased when combined with Rifabutin.
Bisoprolol Bisoprolol The serum concentration of Brentuximab vedotin can be increased when it is combined with Bisoprolol.
Doxazosin Doxazosin The metabolism of Doxazosin can be decreased when combined with Brentuximab vedotin.
Isradipine Isradipine The metabolism of Brentuximab vedotin can be decreased when combined with Isradipine.
Omeprazole Omeprazole The metabolism of Brentuximab vedotin can be increased when combined with Omeprazole.
Cisapride Cisapride The metabolism of Brentuximab vedotin can be decreased when combined with Cisapride.
Fluvastatin Fluvastatin The metabolism of Brentuximab vedotin can be decreased when combined with Fluvastatin.
Famciclovir Famciclovir The metabolism of Famciclovir can be decreased when combined with Brentuximab vedotin.
Fluvoxamine Fluvoxamine The metabolism of Brentuximab vedotin can be decreased when combined with Fluvoxamine.
Nefazodone Nefazodone The metabolism of Brentuximab vedotin can be decreased when combined with Nefazodone.
Losartan Losartan The metabolism of Brentuximab vedotin can be decreased when combined with Losartan.
Tramadol Tramadol The metabolism of Tramadol can be decreased when combined with Brentuximab vedotin.
Vinorelbine Injection Vinorelbine Injection The metabolism of Brentuximab vedotin can be decreased when combined with Vinorelbine.
Carboplatin Injection Carboplatin Injection The risk or severity of adverse effects can be increased when Carboplatin is combined with Brentuximab vedotin.
Lansoprazole Lansoprazole The metabolism of Brentuximab vedotin can be increased when combined with Lansoprazole.
Ifosfamide Injection Ifosfamide Injection The metabolism of Brentuximab vedotin can be increased when combined with Ifosfamide.
Pegaspargase Injection Pegaspargase Injection The risk or severity of adverse effects can be increased when Pegaspargase is combined with Brentuximab vedotin.
Nicardipine Nicardipine The metabolism of Brentuximab vedotin can be decreased when combined with Nicardipine.
Ticlopidine Ticlopidine The metabolism of Ticlopidine can be decreased when combined with Brentuximab vedotin.
Saquinavir Saquinavir The serum concentration of Brentuximab vedotin can be increased when it is combined with Saquinavir.
Gemcitabine Injection Gemcitabine Injection The risk or severity of adverse effects can be increased when Gemcitabine is combined with Brentuximab vedotin.
Ritonavir Ritonavir The serum concentration of Brentuximab vedotin can be increased when it is combined with Ritonavir.
Docetaxel Injection Docetaxel Injection The metabolism of Brentuximab vedotin can be decreased when combined with Docetaxel.
Clomipramine Clomipramine The metabolism of Clomipramine can be decreased when combined with Brentuximab vedotin.
Zafirlukast Zafirlukast The metabolism of Brentuximab vedotin can be decreased when combined with Zafirlukast.
Mirtazapine Mirtazapine The metabolism of Brentuximab vedotin can be decreased when combined with Mirtazapine.
Topiramate Topiramate The metabolism of Brentuximab vedotin can be increased when combined with Topiramate.
Fexofenadine Fexofenadine The serum concentration of Brentuximab vedotin can be increased when it is combined with Fexofenadine.
Azithromycin Azithromycin The metabolism of Azithromycin can be decreased when combined with Brentuximab vedotin.
Carvedilol Carvedilol The serum concentration of Brentuximab vedotin can be increased when it is combined with Carvedilol.
Bicalutamide Bicalutamide The metabolism of Brentuximab vedotin can be decreased when combined with Bicalutamide.
Propafenone Propafenone The serum concentration of Brentuximab vedotin can be increased when it is combined with Propafenone.
Raloxifene Raloxifene The metabolism of Brentuximab vedotin can be decreased when combined with Raloxifene.
Irbesartan Irbesartan The metabolism of Brentuximab vedotin can be decreased when combined with Irbesartan.
Paroxetine Paroxetine The metabolism of Brentuximab vedotin can be decreased when combined with Paroxetine.
Palivizumab Injection Palivizumab Injection The risk or severity of adverse effects can be increased when Palivizumab is combined with Brentuximab vedotin.
Citalopram Citalopram The metabolism of Brentuximab vedotin can be decreased when combined with Citalopram.
Capecitabine Capecitabine The risk or severity of adverse effects can be increased when Capecitabine is combined with Brentuximab vedotin.
Efavirenz Efavirenz The metabolism of Brentuximab vedotin can be increased when combined with Efavirenz.
Sildenafil Sildenafil The serum concentration of Brentuximab vedotin can be increased when it is combined with Sildenafil.
Trastuzumab Injection Trastuzumab Injection Trastuzumab may increase the neutropenic activities of Brentuximab vedotin.
Thalidomide Thalidomide The risk or severity of adverse effects can be increased when Thalidomide is combined with Brentuximab vedotin.
Rabeprazole Rabeprazole The metabolism of Brentuximab vedotin can be decreased when combined with Rabeprazole.
Terbinafine Terbinafine The metabolism of Brentuximab vedotin can be increased when combined with Terbinafine.

Content provided by: AHFS® Patient Medication Information™. © Copyright, 2021. The American Society of Health-System Pharmacists